Nutterova Elena, Fus Martin, Bartosova Libuse, Klimesova Iva, Lestak Jan
Ophthalmology Clinic JL, 155 00 Prague, Czech Republic.
Faculty of Biomedical Engineering, Czech Technical University in Prague, 272 01 Kladno, Czech Republic.
J Clin Med. 2022 Jul 18;11(14):4159. doi: 10.3390/jcm11144159.
The aim of the study was to compare the treatment of hypertensive glaucoma (HTG) in the early stages with carteolol and latanoprost by assessing the change in vessel density (VD) and retinal nerve fibre layer (RNFL). Methods: The first group with diagnosed HTG consisted of 46 eyes treated with carteolol; the second group consisted of 52 eyes treated with latanoprost. The following examinations were evaluated in all patients: intraocular pressure (IOP), retinal nerve fibre layer (RNFL), vessel density (VD) and visual field examination (glaucoma fast threshold test). The results were compared before treatment and 3 months after treatment. Results: There was no difference in the overall visual field defect (OD) between groups before treatment. After treatment, there was a decrease in IOP in both groups (carteolol-treated group had a mean decrease of 5.8 mmHg and latanoprost-treated eyes had a mean decrease of 7 mmHg). This difference was not statistically significant (p = 0.133). No similar difference was observed for RNFL (p = 0.161). In contrast, the change in the VD parameter was statistically significant between groups (p < 0.05), with a greater difference observed in the carteolol-treated group of eyes. Carteolol had a better effect on the VD.
本研究的目的是通过评估血管密度(VD)和视网膜神经纤维层(RNFL)的变化,比较卡替洛尔和拉坦前列素对早期高血压性青光眼(HTG)的治疗效果。方法:确诊为HTG的第一组由46只接受卡替洛尔治疗的眼睛组成;第二组由52只接受拉坦前列素治疗的眼睛组成。对所有患者进行以下检查:眼压(IOP)、视网膜神经纤维层(RNFL)、血管密度(VD)和视野检查(青光眼快速阈值测试)。比较治疗前和治疗3个月后的结果。结果:治疗前两组之间的总体视野缺损(OD)无差异。治疗后,两组眼压均下降(卡替洛尔治疗组平均下降5.8 mmHg,拉坦前列素治疗组平均下降7 mmHg)。这种差异无统计学意义(p = 0.133)。RNFL方面未观察到类似差异(p = 0.161)。相比之下,两组之间VD参数的变化具有统计学意义(p < 0.05),卡替洛尔治疗组的眼睛差异更大。卡替洛尔对VD的效果更好。